Generics News
Most Popular Generics Story
Watson's deal appetite part of generic business shift
When Watson Pharmaceuticals ($WPI) CEO Paul Bisaro expressed an interest in a more-than-bite-size deal, it was just the latest sign that generics makers are looking toward branded drugs for future Read more...
Latest Headlines
- January 12, 2012
- January 4, 2012
- December 19, 2011
- November 17, 2011
- November 16, 2011
- November 14, 2011
- November 4, 2011
- November 3, 2011
- November 1, 2011
- October 19, 2011
- October 7, 2011
- September 22, 2011
- September 9, 2011
- September 8, 2011
- September 6, 2011
- September 1, 2011
- September 1, 2011
- August 24, 2011
- July 28, 2011
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
